REVELATION BIOSCIENCES, INC.

Revelation Biosciences, Inc. (Nasdaq: REVB) is a life sciences company operating in the biosciences and biotechnology sector that filed a Form 10-Q with the Securities and Exchange Commission on June 22, 2021, under accession number 0001213900-21-033574. The company entered public markets during a period of concentrated SPAC activity in the healthcare and biosciences space, reflecting broad investor appetite for life sciences vehicles throughout 2021. As a reporting public company, REVB has disclosed quarterly financial data covering its operations and financial position as it advanced its objectives in the biosciences field. For comprehensive filing histories, deal timelines, and real-time analytics on REVB and the full SPAC universe, sign up for a free SpacDesk account today.